OmarHusseinMaaroufMD
Nephrology • Philadelphia, PAAssociate Professor of Medicine, Thomas Jefferson University
Dr. Maarouf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
33 S 9th St
Suite 700
Philadelphia, PA 19107Phone+1 215-955-6000Fax+1 215-955-8549
Summary
- Dr. Omar Maarouf is a nephrologist in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 15 years. He also speaks multiple languages, including Arabic. He is experienced in glomerular disease, anti-glomerular basement membrane disease, focal segmental glomerulosclerosis, membranous glomerulonephritis, and diabetic kidney disease.
Education & Training
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2010 - 2014
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2007 - 2010
New York Presbyterian Hospital (Cornell Campus)Fellowship, Nephrology, 2005 - 2007
American University of Beirut Faculty of MedicineClass of 2002
Certifications & Licensure
PA State Medical License 2016 - 2024
MA State Medical License 2011 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Faculty Award Thomas Jefferson University, 2018
- Teaching Award Brigham and Women's Hospital, 2013
Clinical Trials
- Urine pH as a Predictor of Diabetes Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- 1 citationsUrinary Neutrophil Gelatinase-Associated Lipocalin Predicts Intensive Care Unit Admission Diagnosis: A Prospective Cohort Study.Goni Katz-Greenberg, Michael Malinchoc, Dennis L Broyles, David Oxman, Seyed M Hamrahian
Kidney360. 2022-09-29 - 29 citationsA Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider.Seyed Mehrdad Hamrahian, Omar H Maarouf, Tibor Fülöp
Patient Preference and Adherence. 2022-01-01 - 7 citationsCase series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports.Christine J Kurian, Zachary French, Patrick Kukulich, Matthew Lankiewicz, Sushil Ghimire
Journal of Medical Case Reports. 2021-12-13
Press Mentions
The Coronavirus Is Damaging Kidneys. Doctors Worry That Some Survivors Will Need Dialysis ForeverAugust 23rd, 2020
Research History
- local PIAMPLITUDE study: A phase 2/3 study to evaluate VX-147 in adults with APOL-1-mediated proteinuric kidney disease.2023 - Present
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
